Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion Imaging

Clinical trial NCT01336140 · COMPLETED

Trial details

NCT number: NCT01336140
Sponsor: Rush University Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson

Start date: 2011-06-01
Primary completion: 2012-05-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.